Search for Abstracts Find by Title, Author or Description Year Abstracts - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first P01 – Predictive Factors of Carcinoid Syndrome (CS) Among Patients with Gastrointestinal Neuroendocrine Tumors (GI NETs) Published in 2017 Listed under P, Poster Download Cai Abstract ID: 217 pdf Download Poster (534 KB) P02 – Economic Burden of Illness of Malignant Lung Neuroendocrine Tumors (NET) Published in 2016 Listed under P, Poster Download Cai pdf Download Poster (352 KB) P03 – Epidemiology of Gastrointestinal Neuroendocrine Tumors (GI-NET) in the US: Analysis of 2 Large Insurance Claims Databases Published in 2016 Listed under P, Poster Download Cai pdf Download Poster (413 KB) P04 – Epidemiology of Neuroendocrine Tumors (NET) of the Lung in the US: Analysis of 2 Large Insurance Claims Databases Published in 2016 Listed under P, Poster Download Cai pdf Download Poster (462 KB) P06 – Carcinoid Tumors of the Ovary: An Observational Cohort Study of 67 Primary and Metastatic Cases Published in 2017 Listed under P, Poster Download Feingold Abstract ID: 280 pdf Download Poster (945 KB) P06 – The Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined to and Extending Beyond the Pancreas Published in 2016 Listed under P, Poster Download Conrad pdf Download Poster (709 KB) P07 – Association Between Duration of Somatostatin Analogs (SSAs) Use and Quality of Life in Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Published in 2017 Listed under P, Poster Download Halperin Abstract ID: 243 pdf Download Poster (354 KB) P08 – Assessment of the Association Between the Burden of Carcinoid Syndrome Symptoms and the Quality of Life Among Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Published in 2017 Listed under P, Poster Download Huynh Abstract ID: 245 pdf Download Poster (282 KB) P09 – International Patient Survey of Physical, Emotional, and Informational Challenges when Living with Neuroendocrine Tumors: Understanding the Unmet Needs Published in 2017 Listed under P, Poster Download Khan Abstract ID: 266 pdf Download Poster (417 KB) P1 - Living with Neuroendocrine Tumors: Assessing Quality of Life (QoL) Through a Mobile Application Published in 2018 Listed under P, Poster Download Abstract ID: 7 Jared Adams, David Ray, Renee Willmon, Anand Gautam, Sonia Pulgar, Arvind Dasari pdf Download Poster (10.50 MB) P10 - Unmet Needs in the Global NETs Patient Community from the Perspectives of Patients, Patient Advocates and NET Health Professionals Published in 2018 Listed under P, Poster Download Abstract ID: 61 Teodora Kolarova, Catherine Bouvier, Martyn Caplin, Siobhan Conroy, Philippa Davies, Sugandha Dureja, Massimo Falconi, Piero Ferolla, George Fisher, Grace Goldstein, Rodney Hicks, Ronald Hollander, Ben Lawrence, Simone Leyden, Yoshiyuki Majima, David Metz, Dermot O’Toole, Philippe Ruszniewski, Bertram Wiedenmann pdf Download Poster (1.44 MB) P11 - Clinicopathological Features of 66 Cases of Type 3 Gastric Neuroendocrine Neoplasms: A Retrospective Analysis Published in 2018 Listed under P, Poster Download Abstract ID: 51 Xudong Qiu, Dou Dou, Yu Zhang, Qing Liu, Jixi Liu, Jie Luo, Pan Zhang, Yuanliang Li, Fei Su, Zhirong Qi, Jie Chen, Huangying Tan pdf Download Poster (536 KB) P11 – Evaluation of the Impact of the Burden of Carcinoid Syndrome Symptoms on Quality of Life Among Treated Patients with Carcinoid Syndrome in the U.S. Based on the PROMIS–29 Instrument Published in 2017 Listed under P, Poster Download Neary Abstract ID: 244 pdf Download Poster (321 KB) P12 - Lanreotide vs. Octreotide-LAR for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Observational Time and Motion Analysis Published in 2018 Listed under P, Poster Download Abstract ID: 78 Pamela Ryan, Ali McBride, David Ray, Sonia Pulgar, Robert Ramirez, Emad Elquza, Justin Favaro, George Dranitsaris pdf Download Poster (9.30 MB) P13 - Comparison of Quality of Life Measurement Tools, EORTC GINET21 and ESAS-r, in Patients with Gastroenteropancreatic Neuroendocrine Tumors and Considerations for Clinical Implementation Published in 2018 Listed under P, Poster Download Abstract ID: 108 Bianka Saravana-Bawan, Marguerite Wieler, Todd McMullen, Alexander McEwan pdf (1.04 MB) pdf Download Poster (321 KB) P14 - Incidence of Neuroendocrine Tumors in the Ethnically/Racially Diverse Population of New Mexico Published in 2018 Listed under P, Poster Download Abstract ID: 75 Heloisa Soares, David Martin, Angela Meisner, Damian Fountain, Charles Wiggins pdf Download Poster (321 KB) P15 - The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased Among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms - A Nationwide Population Based Study Published in 2018 Listed under P, Poster Download Abstract ID: 16 Tobias Stemann Lau, Gitte Dam, Peter Jepsen, Henning Grønbæk, Klaus Krogh, Tine Gregersen pdf Download Poster (1.15 MB) P16 - Practice Patterns, Challenges and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients. Published in 2018 Listed under P, Poster Download Abstract ID: 22 Radhika Yelamanchili, Alia Thawer, David Chan, Dorothy Lo, Simron Singh, Warren Fingrut, David Wyld pdf Download Poster (350 KB) P2 - Incidental Histological Diagnosis of Small Pancreatic Neuroendocrine Tumours: Are We Underestimating Their Incidence? Published in 2018 Listed under P, Poster Download Abstract ID: 60 Valentina Andreasi, Stefano Partelli, Fabio Giannone, Francesca Muffatti, Gianpaolo Balzano, Stefano Crippa, Domenico Tamburrino, Roberto Montorsi, Giuseppe Zamboni, Corrado Rubini, Claudio Doglioni, Massimo Falconi pdf Download Poster (362 KB) P3 - The Cost-Effectiveness of Initial vs. Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors in the United States Published in 2018 Listed under P, Poster Download Abstract ID: 114 James I. Barnes, John Lin, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert, Pamela L. Kunz pdf Download Poster (812 KB) P4 - A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors Published in 2018 Listed under P, Poster Download Abstract ID: 14 Gitte Dam, Henning Groenbaek, Halfdan Soerbye, Espen Thiis Evensen, Björn Paulsson, Anders Sundin, Claus Jensen, Dyveke Ebbesen, Ulrich Knigge, Eva Tiensuu Janson pdf Download Poster (453 KB) P5 - Ontario Oncologists’ Perspectives on Addressing Potential Barriers in the Management of Patients with Neuroendocrine Tumors Published in 2018 Listed under P, Poster Download Abstract ID: 47 Warren Fingrut, Radhika Yelamanchili, Alia Thawer, David Chan, David Wyld, Simron Singh, Dorothy Lo pdf Download Poster (349 KB) P6 - Integrating Patient Reported Outcomes (PROs) in Neuroendocrine Tumors (NETs) Care: An Assessment of Cognitive and Psychological Screening Tools During Follow-Up Published in 2018 Listed under P, Poster Download Abstract ID: 44 Kailtyn Beyfuss, Sten Myrehaug, David Chan, Simron Singh, Calvin Law pdf Download Poster (703 KB) P7 - Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population- Based Analysis of Patient-Reported Outcomes Published in 2018 Listed under P, Poster Download Abstract ID: 11 Julie Hallet Laura Davis Alyson Mahar Calvin Law Elie Isenger-Grzeda Lev Bubis Simron Singh Sten Myrehaug Haoyu Zhao Kaitlyn Beyfuss Lesley Moody Natalie Coburn pdf Download Poster (318 KB) P8 - Association of 5HIAA and Mortality in Neuroendocrine Tumor Patients: A Systematic Review and Meta-Analysis Published in 2018 Listed under P, Poster Download Abstract ID: 35 Vijay N. Joish, Sandip Shah, Helen Shao, Chad McKee, Pablo Lapuerta, Jerome Zacks pdf Download Poster (1.22 MB) T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin Published in 2017 Listed under Poster, T Download Chan Abstract ID: 295 pdf Download Poster (579 KB) T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor Published in 2017 Listed under Poster, T Download Hope Abstract ID: 309 pdf Download Poster (671 KB) T03 – SPINET: A Randomized, Double-blind, Placebo-controlled Phase III Study of Lanreotide Autogel/Depot (LAN) in Patients with Advanced Lung Neuroendocrine Tumors Published in 2016 Listed under Poster, T Download Reidy-Lagunes pdf Download Poster (804 KB) T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors Published in 2017 Listed under Poster, T Download Nicolas Abstract ID: 285 pdf Download Poster (849 KB) T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET) Published in 2017 Listed under Poster, T Download Soulen Abstract ID: 311 pdf Download Poster (475 KB) T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen Published in 2017 Listed under Poster, T Download Yao Abstract ID: 242 pdf Download Poster (848 KB) T1 - A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After at Least One Prior Regimen for Metastatic Disease Published in 2018 Listed under Poster, T Download Abstract ID: 81 Aman Chauhan, Susanne Arnold, Stacey Slone, Emily Dressler, Lowell Anthony pdf Download Poster (495 KB) T2 - A Pilot Study of Pembrolizumab and Liver-Directed Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Liver Metastases Published in 2018 Listed under Poster, T Download Abstract ID: 110 Nicholas Fidelman Emily Bergsland Lawrence Fong pdf Download Poster (246 KB) T3 - Pembrolizumab-Based Therapy in Previously Treated High Grade Extrapulmonary Neuroendocrine Carcinomas Published in 2018 Listed under Poster, T Download Abstract ID: 96 Claire K. Mulvey, Claire Hooker, Jennifer A. Chan, Rahul Raj Aggarwal, Pelin Cinar, Thomas A. Hope, K. Pallav Kolli, Li Zhang, Susan Calabrese, Jennifer A. Grabowsky, Diane Reidy-Lagunes, Lawrence Fong, Nitya Prabhakar Raj, Emily K. Bergsland pdf (2.24 MB) pdf Download Poster (2.24 MB) T4 - A Pilot Phase 2 Study of Albumin-Bound Rapamycin Nanoparticles, ABI-009, in Patients with Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors (NETs) of the Lung or Gastroenteropancreatic System Published in 2018 Listed under Poster, T Download Abstract ID: 63 Robert A. Ramirez, Marc Matrana, Suma Satti, Ryan P. Griffin, Ramcharan Thiagarajan, J. Philip Boudreaux, Eugene A. Woltering pdf Download Poster (385 KB) [B10] Haas - Novel Fusion Gene UBTF-MAML3 Drives Tumorigenesis in Neuroendocrine Tumor Cells Published in 2021 Listed under Poster Download [B11] Guenter - Variability of Somatostatin Receptor Type 2 Immunohistochemical Staining Patterns Among Published in 2021 Listed under Poster Download [B12] Keutgen - Sunitinib-loaded Chondroitin Sulfate Hydrogels as a Novel Drug-delivery Mechanism for the Treatment of Pancreatic Published in 2021 Listed under Poster Download [B13] Jacenik - The MAP Kinase-activated Protein Kinase 2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Involving Action Mediated by Published in 2021 Listed under Poster Download [B15] Tran - Comparison of Drug Sensitivity Profiles of Various NEN Spheroids Published in 2021 Listed under Poster Download [B16] Chauhan - Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [B17] Liu - Pre-clinical Evaluation of Alpha-particle Radiotherapy Targeting CXCR4 in Small Cell Lung Cancer Published in 2021 Listed under Poster Download [B1] Ivanov - Sex-specific Transcriptional Differences and Loss of Gene Imprinting in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B2] Tran - RNA-sequencing Identifies Unique Molecular Features of Duodenal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B3] Guo - Cd36 Mediated Metabolic Reprogramming in Cancer Stem Cells Contributes to Drug Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B4] Keutgen - Loss of MEN1 Function Inhibits DNA Repair Capability of Pancreatic Neuroendocrine Tumors after Radiation Published in 2021 Listed under Poster Download [B5] Shaikamjad - RABL6A-Myc Signaling Promotes Pancreatic Neuroendocrine Tumor Cell Proliferation and Survival Published in 2021 Listed under Poster Download [B6] Ear - Inhibition of Serotonin Biosynthesis Suppresses Tumor Published in 2021 Listed under Poster Download [B7] Armstrong - Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-like Pheochromocytomas Published in 2021 Listed under Poster Download [B8] Tow - Development of a Real-time Luminescent Sensor for Detecting Serotonin Levels in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B9] Whitt - Natural Compound Verrucarin A Potentiates the Anticancer Effect of Etoposide in NET Cell Lines Published in 2021 Listed under Poster Download [C10] McGarrah - Genomic Profiling of Responders and Non-responders to Checkpoint Inhibition in Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C11] Desai - Lurbinectedin in Extrapulmonary Metastatic Neuroendocrine Carcinomas Published in 2021 Listed under Poster Download [C12] Khuong Le - Urinary Neuroendocrine Neoplasms (NENs) Treated in the "Modern Era": A Multicenter Retrospective Review Published in 2021 Listed under Poster Download [C13] Bai - Health-related Quality-of-life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep) Published in 2021 Listed under Poster Download [C14] Mohamed - Exploring Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C15] Al-Toubah - Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C16] Al-Toubah - Efficacy of Ipilimumab and Nivolumab in Patients with Highgrade Neuroendocrine Neoplasms Published in 2021 Listed under Poster Download [C17] Hauser - Treatment Response and Clinical Outcomes of Neuroendocrine Neoplasms (NENs) Treated with Immune Checkpoint Inhibitors (ICIs): a Single Institution Experience Published in 2021 Listed under Poster Download [C18] Shen - A Phase 2 Study of Surufatinib in Combination with Toripalimab in Patients with Advanced Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C19] Chan - Phase 2 Trial of Pembrolizumab-based Therapy in Previously Treated Extrapulmonary Poorly-differentiated Neuroendocrine Carcinomas: Results of Part B Published in 2021 Listed under Poster Download [C1] Gile - Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy in Patients with High-grade Extrapulmonary Published in 2021 Listed under Poster Download [C20] Raj - Randomized Blinded Study Comparing Injection Site Pain From Octreotide Long-acting-release (LAR) Versus Lanreotide During the Treatment of Well-differentiated Published in 2021 Listed under Poster Download [C21] Das - Validation of a Clinical Score (CS) for Patients With WellDifferentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C22] Attiyeh - Defining MRI Superiority Over CT for Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C23] Wong - Long-term Outcomes Following 90YRadioembolization of Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C24] Badawy - Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS) Published in 2021 Listed under Poster Download [C25] Weekley - Comparing Periprocedural Hemodynamic Instability in Y-90 Radioembolization and Bland Embolization for Neuroendocrine Tumor Liver Metastases Published in 2021 Listed under Poster Download [C26] Duan - Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Published in 2021 Listed under Poster Download [C27] Zhou - Subgroup Analysis by Ki-67 and Primary Tumor Origins of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Extrapancreatic Neuroendocrine Tumors (SANET-ep) Published in 2021 Listed under Poster Download [C28] Yu - Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Pancreatic Published in 2021 Listed under Poster Download [C29] Clement - Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Advanced Pancreatic Neuroendocrine Tumours (panNETs): Data From the NETTER-R International, Published in 2021 Listed under Poster Download [C2] Mohamed - The Role of Microbiome in Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) Published in 2021 Listed under Poster Download [C30] Halfdanarson - Compose: Pivotal Phase III Trial of 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade 2 and Grade 3 Gastroenteropancreatic Published in 2021 Listed under Poster Download [C31] Grønbæk - Safety and Effectiveness of 177Lu-Satoreotide Tetraxetan in Patients with Progressive Neuroendocrine Tumors (NETs): Interim Analysis of a Phase I/II Study Published in 2021 Listed under Poster Download [C32] Kunz - The Phase 3 NETTER-1 Study of 177Lu-DOTATATE in Patients with Midgut Neuroendocrine Tumors: Updated Published in 2021 Listed under Poster Download [C33] Norman - Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine Published in 2021 Listed under Poster Download [C34] Pryma - Secondary Hematological Malignancies Following Highspecific Activity Iodine-131 Metaiodobenzylguanidine Treatment of Advanced Pheochromocytoma and Published in 2021 Listed under Poster Download [C35] Manohar - 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: a Single Center Experience Published in 2021 Listed under Poster Download [C36] Soulen - Cap-Tem-Y90 for Grade 2 Liver-dominant Net Metastases Published in 2021 Listed under Poster Download [C37] Coffman - Treatment Response and Clinical Outcomes of Well-differentiated (WD) High-grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE Published in 2021 Listed under Poster Download [C38] Lawhn-Heath - Clinical Utility of Qualitative Post-treatment SPECT After Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C39] Bodei - Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C3] Li - Patient-reported Clinical and Productivity Outcomes From the Longitudinal Telotristat Ethyl Treatment Registry Published in 2021 Listed under Poster Download [C40] Gococo-Benore - Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients Published in 2021 Listed under Poster Download [C41] Gupta - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients with Bulky and/or Progressive Metastatic Well Differentiated Neuroendocrine Published in 2021 Listed under Poster Download [C42] Zan - A Case of G3-WD Gastric Carcinoid Tumor in a MEN1 Patient with Discrepant Treatment Response to PRRT in Published in 2021 Listed under Poster Download [C43] Malhotra - MRI Has Improved Detection of Small Neuroendocrine Liver Metastasis Compared with Ga-68 DOTATATE Published in 2021 Listed under Poster Download [C44] Gudmundsdottir - Multifocality Is Not Associated with Worse Survival in Sporadic Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C45] Tran - Management of Duodenal Neuroendocrine Tumors: Surgical Versus Endoscopic Mucosal Resection Published in 2021 Listed under Poster Download [C46] Gudmundsdottir - Alternative Lengthening of Telomeres Is Associated with Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C47] Shi - Pathologic Features of Small Pancreatic Neuroendocrine Tumors with Liver Metastasis Published in 2021 Listed under Poster Download [C48] Shi - Venous Invasion in Resected Pancreatic Neuroendocrine Tumors Is Independently Associated with Disease Free Published in 2021 Listed under Poster Download [C49] Watanabe - Importance of Grade in the Surgical Management of Rectal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C50] Slattery - Detection Method and Overall Survival in Surgically Resected Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C51] Naaseh - A Single-Center Experience in Observation of Small Pancreatic Neuroendocrine Tumors: To Operate or Not to Published in 2021 Listed under Poster Download [C52] Nguyen - Role of Chromogranin A in the Diagnosis and Follow up of Neuroendocrine Neoplasms: Real World Review Published in 2021 Listed under Poster Download [C53] Pommier - A Prospective Study of Carcinoid Crisis with No Perioperative Octreotide Published in 2021 Listed under Poster Download [C54] Herring - Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors from Black and White Published in 2021 Listed under Poster Download [C55] Pulvirenti - Early Onset Well Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and Published in 2021 Listed under Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 «12345»
